Results of a study investigating chidamide combined with chemoimmunotherapy for treatment of relapsed DLBCL.
Home / Resource Library / Chidamide, a Histone Deacetylase Inhibitor, Combined With R-GemOx in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (TRUST): A Multicenter, Single-Arm, Phase 2 Trial